International Clinical Trial: Correlation of peripheral blood F13A1 expression and super-enhancer chr6:6474317 activity with coagulation dysfunction and prognosis in patients with acute respiratory distress syndrome (ARDS)

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128892) titled 'Correlation of peripheral blood F13A1 expression and super-enhancer chr6:6474317 activity with coagulation dysfunction and prognosis in patients with acute respiratory distress syndrome (ARDS)' on July 27.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Shandong Provincial Third Hospital

Condition: Acute respiratory distress syndrome (ARDS)

Intervention: Healthy control group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-07-31

Target Sample Size: Healthy control group:10;ARDS patient group:60;

Countries of Recruitment: China

To know m...